undamentalytics Newsletter
Sign in

Staar Surgical Co cash flow statement

In fiscal 2025, Staar Surgical Co's operations generated −$34.2m of cash; it spent $5.8m on capital projects, leaving free cash flow of −$40.0m. It returned $6.5m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Jan 20102010Dec 20102011Dec 20112012Dec 20122013Jan 20142014Jan 20152015Jan 20162016Dec 20162017Dec 20172018Dec 20182019Jan 20202020Jan 20212021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Jan 2026LTMJul 2026
Cash from operations1−4533−8−21313262144361516−34−3
Depreciation and amortisation221122233243445789
Stock-based pay11234539371112152024273128
Capital spending10123423121081418182363
Free cash flow1−541−0−12−4−221116133018−4−8−40−7
Free cash flow after stock pay−1−62−2−5−17−8−11−145016−3−27−35−71−35
Share buybacks————————————————6—
Shares issued9————————72————————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: PRCT vs STAAINGN vs STAAANGO vs STAASTAA vs TCMD

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Staar Surgical Co's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Staar Surgical Co.